SG160201A1 - Electroprocessing in drug delivery and cell encapsulation - Google Patents
Electroprocessing in drug delivery and cell encapsulationInfo
- Publication number
- SG160201A1 SG160201A1 SG200700665-3A SG2007006653A SG160201A1 SG 160201 A1 SG160201 A1 SG 160201A1 SG 2007006653 A SG2007006653 A SG 2007006653A SG 160201 A1 SG160201 A1 SG 160201A1
- Authority
- SG
- Singapore
- Prior art keywords
- drug delivery
- electroprocessing
- substance
- compositions
- cell encapsulation
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title abstract 2
- 238000005538 encapsulation Methods 0.000 title 1
- 239000000126 substance Substances 0.000 abstract 6
- 239000000463 material Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 229920002994 synthetic fiber Polymers 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention is directed to novel compositions comprising an electroprocessed material and a substance, their formation and use. The electroprocessed material can, for example, be one or more natural materials, one or more synthetic materials, or a combination thereof. The substance can be one or more therapeutic or cosmetic substances or other compounds, molecules, cells, vesicles. The compositions can be used in substance delivery, including drug delivery within an organism by, for example, releasing substances or containing cells that release substances. The compositions can be used for other purposes, such as prostheses or similar implants.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24100800P | 2000-10-18 | 2000-10-18 | |
| US71425500A | 2000-11-17 | 2000-11-17 | |
| US27011801P | 2001-02-22 | 2001-02-22 | |
| US09/946,158 US20020042128A1 (en) | 2000-09-01 | 2001-09-04 | Electroprocessed fibrin-based matrices and tissues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG160201A1 true SG160201A1 (en) | 2010-04-29 |
Family
ID=42269903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200700665-3A SG160201A1 (en) | 2000-10-18 | 2001-10-18 | Electroprocessing in drug delivery and cell encapsulation |
Country Status (1)
| Country | Link |
|---|---|
| SG (1) | SG160201A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114980908A (en) * | 2020-01-13 | 2022-08-30 | 因库博实验室有限责任公司 | Cell delivery article and method of administration |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4043331A (en) * | 1974-08-05 | 1977-08-23 | Imperial Chemical Industries Limited | Fibrillar product of electrostatically spun organic material |
| WO1998003267A1 (en) * | 1996-07-23 | 1998-01-29 | Electrosols Ltd. | A dispensing device and method for forming material |
-
2001
- 2001-10-18 SG SG200700665-3A patent/SG160201A1/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4043331A (en) * | 1974-08-05 | 1977-08-23 | Imperial Chemical Industries Limited | Fibrillar product of electrostatically spun organic material |
| WO1998003267A1 (en) * | 1996-07-23 | 1998-01-29 | Electrosols Ltd. | A dispensing device and method for forming material |
Non-Patent Citations (1)
| Title |
|---|
| ELECTROSPINNING PROCESS AND APPLICATIONS OF ELECTROSPUM FIBERS * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114980908A (en) * | 2020-01-13 | 2022-08-30 | 因库博实验室有限责任公司 | Cell delivery article and method of administration |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO962088D0 (en) | Preparation for in vivo production of therapeutic products | |
| DE60023520D1 (en) | LIQUID HIGH VISIBLE SYSTEM WITH CONTROLLED RELEASE AND MEDICAL OR SURGICAL DEVICE | |
| AP2002002552A0 (en) | Pharmaceutical compositions providing enhanced drug concentrations. | |
| ATE288258T1 (en) | BIODEGRADABLE POLYMER COMPOSITION | |
| MY122391A (en) | Piperazine derivatives as 5-ht1b antagonists | |
| BR0008590A (en) | Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed | |
| PT1137400E (en) | COMPOSITIONS CONTAINING A PEPTIDE AND A POLYLACTIC-GLYCOLIC ACID SUITABLE FOR PREPARING SUBSCUTANEOUS IMPLANTS WITH A PROLONGED LIBERATION PERIOD | |
| ATE324907T1 (en) | COMPOUND AND MEDICINAL COMPOSITION FOR ADMINISTRATION OF ACTIVE INGREDIENTS | |
| IS4083A (en) | Composition of pharmaceutical substances, method of manufacture thereof, and use as pharmaceuticals | |
| ATE402002T1 (en) | ELECTROPROCESSED COLLAGEN | |
| EP0283713A3 (en) | Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them | |
| WO2004052336A3 (en) | High viscosity liquid controlled delivery system and medical or surgical device | |
| AU2845599A (en) | Pharmaceutical compositions and their use | |
| BR0114839A (en) | composition, and method of releasing a substance or electroprocessed material at a desired location | |
| DE60024414T2 (en) | OXADIAZOL COMPOUNDS AND COMPOSITIONS FOR THE DISPOSAL OF ACTIVE SUBSTANCES | |
| EP1493754A4 (en) | Polysaccharide containing phosphorylcholine group and process for producing the same | |
| ATE271387T1 (en) | MEDICINAL PREPARATIONS CONTAINING VITAMIN D AND CALCIUM, THEIR PRODUCTION AND THERAPEUTIC USE | |
| WO2003086290A3 (en) | Electroprocessing of materials useful in drug delivery and cell encapsulation | |
| DE50004443D1 (en) | COMPOSITION CONTAINING ACTIVE SUBSTANCE AND THEIR PRODUCTION AND USE | |
| HUP0300917A3 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them | |
| DE50112438D1 (en) | DENTAL CARE IN PORTION CAPSULES | |
| ES2152432T3 (en) | IMPLANTABLE DEVICE FOR THE ADMINISTRATION OF ACTIVE PRINCIPLES TO VEGETABLE SPECIES. | |
| MY140724A (en) | Novel arylethene-sulfonamides | |
| SG160201A1 (en) | Electroprocessing in drug delivery and cell encapsulation | |
| TR200401462T4 (en) | A stable pharmaceutical formulation comprising torsemide modification II |